US Patent 7542379 Mobile medication
Patent 7542379 was granted and assigned to Intel on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+463 characters)
Article
Patent abstract
A mobile medication device including a timekeeping unit, which may be a wrist watch and may include a microprocessor, to track a plurality of time events associated with a plurality of medications to given to a user, wherein the time events may be specific times at which a particular medication is to be taken by the user, and may also include additional events such as a predetermined time prior to when the user is supposed to take a medication.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07542379 Mobile medication US Patent 7542379 Mobile medication
Infobox
Patent Number
0754237900
Patent Number
754237900
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075423790
Date of Patent
June 2, 2009
0Patent Application Number
116440160
Date Filed
December 22, 2006
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075423790
Date of Patent
June 2, 2009
0Patent Application Number
116440160
Date Filed
December 22, 2006
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07542379 Mobile medication
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07542379
Date of patent
June 2, 2009
Patent application number
11644016
Date Filed
December 22, 2006
Patent primary examiner
Find more entities like US Patent 7542379 Mobile medication
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
